Novohope's manufacturing base in Wuxi, China

Pet Health Supplement OEM: The Long-Term Oral Film Partnership Guide

Choosing the right manufacturer for your pet health supplements is a long-term decision. It affects product quality, regulatory compliance, supply stability, and consumer trust. The global pet supplement market is expanding quickly, and oral dissolvable film (ODF) technology has emerged as a practical format for functional pet care. This guide explains how a long-term OEM partnership with a specialized ODF manufacturer can support your product roadmap, from sample orders to scaled production.

Problem Definition: Why Short-Term Sourcing Undermines Pet Supplement Brands

Many pet supplement brands approach sourcing as a series of one-off transactions. That creates recurring problems: inconsistent batches, incomplete compliance documents, limited formulation control, and little room to adapt when market demand changes. In a category where safety, labeling, and product claims matter, the cost of switching suppliers can be high.

There is also a product-level challenge. Traditional formats—tablets, capsules, powders, liquids—often cause pet resistance. Giving medicine can become a psychological tug-of-war, with some pets vomiting, refusing to swallow, or resisting until the owner gives up. Some pet hospitals even charge separately for the feeding service. A supplier that only manufactures a standard pill cannot solve this. A long-term partner should contribute formulation science, regulatory knowledge, and a format that pets actually accept.

Industry Background: The Pet Supplement Market and the Shift Toward Oral Film Formats

Market data supports the need for new formats. According to Grand View Research, the global pet supplements market is valued at approximately USD 2.8 billion in 2025, with projected growth to USD 4.6 billion by 2033. North America captures 48.1% of global revenue share, while Asia-Pacific is projected to be the fastest-growing region. Mordor Intelligence estimates the pet dietary supplements segment will reach USD 5.11 billion by 2026, with a CAGR of 7.42% through 2031.

Oral dissolvable film (ODF) is moving from human pharma into pet care. Market Reports World reports that ODF innovations in the pet sector are focusing on disintegration times below 25 seconds and palatability improvements of up to 47%. These trends create a clear opening for brands that can secure a reliable, compliant ODF supply partner early.

Detailed Solution: Novohope's Long-Term Partnership Model

Novohope (officially Wuxi Novohope Biotechnology Co., Ltd.) offers a long-term partnership model built around oral melt film technology. The company was established in September 2025 and is based in Wuxi, Jiangsu Province, China. Its technical team comes from the Wahsheer Biotechnology Laboratory at the Chinese University of Hong Kong, an institution associated with Nobel Prize-winning researchers. In June 2026, Novohope opened a new R&D and marketing center in Shekou, Shenzhen. In July 2026, all products completed FDA food registration, obtained GS1 international product codes, and passed SDS and COA professional certifications. For brands, these are important baseline capabilities.

Technology Platform: Oral Fast-Dissolving Films

The core product is an oral melting film roughly the size of a postage stamp. When it comes into contact with pet saliva, it melts within 10 seconds, and active ingredients are absorbed through the oral mucosa directly into the bloodstream. Novohope states an absorption rate of up to 95%, compared with approximately 25–35% gastrointestinal absorption for traditional pet medicines and foods. This difference matters for efficacy, especially for vitamins, probiotics, and antioxidants that can be degraded in the stomach.

The film also reduces the burden on the pet owner. The company reports that feeding is 5 to 10 times faster than traditional methods, and the format can be used at home, outdoors, or anywhere.

Product Portfolio: Seven Functional Series

Novohope has designed seven product series: COAT+ for coat and skin, EYES+ for eye care and tear stain, CALM+ for calming and stress relief, BONE+ for joint care, HEART+ for cardiovascular support, PROBIO for digestive care, and Fit+ for weight management. Each series uses an oral fast-dissolving matrix with targeted ingredients. For example, BONE+ includes glucosamine HCl, hydrolyzed collagen peptides, and undenatured type II collagen; EYES+ includes lutein and zeaxanthin; PROBIO includes Bacillus coagulans and postbiotics. A brand can build a complete functional care portfolio with one partner instead of managing multiple suppliers.

Compliance and Quality Infrastructure

Quality control is built into the production process. Novohope states that it has a mature factory quality control system, and all products undergo strict quality and product certifications before they are sold. The control methods include product certification, test reports, production-process control, and an after-sales team. In July 2026, the company completed FDA food registration and obtained GS1 international product codes. It also passed SDS and COA certifications. These documents are directly useful for importers and retailers when they conduct supplier qualification.

Novohope's R&D and marketing center in Shenzhen

R&D and Manufacturing Capacity

The company operates a 20,000 m² facility and reports an annual output capacity of 200,000,000 boxes. It has 25 employees, including 12 R&D engineers. Approximately 95% of production is exported, mainly to Europe, America, Britain, the Middle East, Japan and South Korea. The company has also been selected for the 'Feifeng Talent Program' Leading Technological Talent Project in 2025 and shortlisted for the 2026 Wuxi Taihu Cup International Innovation Competition. For brands, these signals help in assessing organizational stability and scale.

International pet exhibition in Nuremberg, Germany (May 2026)

Why the Oral Film Format Reduces Execution Risk

For a brand owner or distributor, the format is not just an ingredient delivery system. It affects how quickly a product can be adopted by consumers. A thin film that dissolves in the mouth removes several barriers to daily supplement use. It helps pet owners who travel, have anxious pets, or manage multiple pets. Because the film is small and shelf-stable, it also simplifies packaging and shipping compared with liquids or bulk powders.

Step-by-Step Breakdown: From Initial Inquiry to Long-Term Execution

Follow these steps to move from initial inquiry to a long-term supply arrangement.

Step 1: Define Your Product Brief

Start by identifying the target pet health concern, the active ingredients, and the sales market. Novohope's seven product series cover the most common functional categories. You should also confirm the regulatory documents required in your target country, such as ingredient declarations or registration certificates.

Step 2: Request Samples for Evaluation

Novohope supports sample orders with a MOQ of 1 unit. The sample can be shipped on DDP terms, which means the supplier handles delivery and import procedures. The acceptance process includes pre-shipment full inspection, third-party authoritative testing, and a COA quality report. Payment is full before shipment. This step lets you evaluate the film texture, palatability, and packaging before committing to a larger batch.

Step 3: Customize Formulation and Branding

For OEM/ODM projects, you can adapt the formulation and branding. Novohope lists manufacturing, contract manufacturing, research and development, and brand agency as its applicable industries. Use an existing series as a starting point, then work with the R&D team to adjust ingredients, flavor, or packaging according to your brand position.

Step 4: Prepare for Bulk Procurement

For bulk orders, the MOQ is 1000 boxes per SKU. Delivery terms can be FOB or CIF. Payment terms are 50% deposit / 50% balance. This structure is typical for international B2B supplement orders and allows both sides to manage production and logistics more predictably.

Step 5: Implement Pre-Shipment Quality Checks

Every order includes a pre-shipment inspection. For sample orders, the inspection is a full inspection with third-party testing and a COA. For bulk orders, pre-shipment testing ensures batch consistency. This step creates a transparent quality audit trail, which is valuable when you later need to provide documents to retailers or regulators.

Step 6: Build the Long-Term Relationship

After the first order, maintain communication with the after-sales team and share market feedback. Because Novohope already exports to Europe, America, Britain, the Middle East, Japan and South Korea, it can help you adapt to evolving compliance requirements. Long-term relationships also make it easier to plan seasonal inventory, launch new SKUs, and refine formulations as consumer preferences shift.

Use Cases: Who Benefits from a Long-Term Oral Film OEM Partnership?

Here are three common scenarios for a long-term oral film OEM partnership.

Emerging Pet Brands

A new brand can use Novohope's ODM capability to launch quickly. By choosing an existing series—for example, EYES+ for tear stain care—and applying its own brand and packaging, the brand can enter the market without building a factory. The sample-first process (MOQ 1 unit) reduces initial risk.

Established Pet Food Companies

A mature company in pet food or pet healthcare may want to extend its range with functional supplements. Instead of investing in a new production line, it can contract Novohope's R&D and manufacturing capacity. The seven series allow the company to test multiple SKUs and keep a consistent brand story across categories.

Distributors and Importers

Importers supplying pet retail chains need a supplier that can provide documentation and stable output. Novohope's FDA registration, GS1 codes, and COA reports help importers complete supplier qualifications. The monthly volume capacities and export experience across major markets support channel expansion.

Comparison Table: Novohope Oral Film vs Traditional Pet Supplement Formats

FAQ

What compliance certifications does Novohope have for pet health supplement oral films?

In July 2026, Novohope completed FDA food registration for all products and obtained GS1 international product codes. The company also passed SDS and COA professional certifications. Novohope operates a mature factory quality control system, and all products undergo strict quality and product certifications before they are sold.

Can Novohope support OEM/ODM projects for oral film pet supplements?

Yes. Novohope lists manufacturing, contract manufacturing, research and development, and brand agency as applicable industries. The company offers seven oral film product series: COAT+, EYES+, CALM+, BONE+, HEART+, PROBIO, and Fit+. Its R&D team includes 12 engineers, and it opened an R&D and marketing center in Shenzhen in June 2026.

What are the minimum order quantities and payment terms for Novohope pet supplement orders?

For sample evaluation, the minimum order quantity is 1 unit, with delivery on DDP terms and payment in full before shipment. For bulk OEM orders, the MOQ is 1000 boxes per SKU, delivery is on FOB or CIF terms, and payment is 50% deposit / 50% balance.

How can a brand obtain samples of Novohope oral film supplements?

Sample orders can be placed with a MOQ of 1 unit. Each sample order includes pre-shipment full inspection, third-party authoritative testing, and a COA quality report. Delivery can be arranged on DDP terms, and full payment is required before shipment.

What delivery and acceptance process should a buyer expect?

For sample orders, delivery is arranged on DDP terms, meaning the supplier manages delivery and import procedures. For bulk orders, FOB or CIF terms apply. Acceptance includes pre-shipment inspection; sample orders include third-party testing and COA documentation, while bulk orders include pre-shipment testing. You can contact Novohope directly for a delivery schedule tailored to your project.

Conclusion

Long-term sourcing decisions in pet health supplements are about more than price per unit. The format determines whether the active ingredients are delivered efficiently; the supplier determines whether your brand can meet compliance requirements across borders. Novohope's oral dissolvable film platform, seven-series portfolio, documented FDA registration, and export experience provide a foundation for a durable partnership. If you are comparing manufacturers or planning a launch, start with a sample order and verify the relevant certifications.

Novohope BONE+ product series

Ready to evaluate Novohope as a long-term oral film partner? Download the company brochure to review the product range and manufacturing details. For sample requests or OEM/ODM inquiries, contact Frank at NovoHope.pet@outlook.com or call +86 1342809561.